Recombinant blood group proteins for use in antibody screening and identification tests.
OBJECTIVE
The present review elucidates the potentials of recombinant blood group proteins (BGPs) for red blood cell (RBC) antibody detection and identification in pretransfusion testing and the achievements in this field so far.


RESULTS
Many BGPs have been eukaryotically and prokaryotically expressed in sufficient quantity and quality for RBC antibody testing. Recombinant BGPs can be incorporated in soluble protein reagents or solid-phase assays such as ELISA, color-coded microsphere and protein microarray chip-based techniques. Because novel recombinant protein-based assays use single antigens, a positive reaction of a serum with the recombinant protein directly indicates the presence and specificity of the target antibody. Inversely, conventional RBC-based assays use panels of human RBCs carrying a huge number of blood group antigens at the same time and require negative reactions of samples with antigen-negative cells for indirect determination of antibody specificity.


CONCLUSIONS
Because of their capacity for single-step, direct RBC antibody determination, recombinant protein-based assays may greatly facilitate and accelerate the identification of common and rare RBC antibodies.
Seltsam
Axel
A
German Red Cross Blood Service NSTOB, Institute Springe, Springe, Germany. axel.seltsam@bsd-nstob.de
Blasczyk
Rainer
R
D000906:Antibodies / Q000032:analysis*; D001789:Blood Group Antigens / Q000737:chemistry*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D006801:Humans; D011933:Reagent Kits, Diagnostic; D011994:Recombinant Proteins / Q000737:chemistry*
D000906:Antibodies; D001789:Blood Group Antigens; D011933:Reagent Kits, Diagnostic; D011994:Recombinant Proteins